[HTML] sciencedirect.comFull View

[HTML][HTML] Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies

PC Wong, EJ Crain, B Xin, RR Wexler, PYS Lam… - Journal of Thrombosis …, 2008 - Elsevier
Background: Apixaban is an oral, direct and highly selective factor Xa (FXa) inhibitor in late‐
stage clinical development for the prevention and treatment of thromboembolic diseases …
被引用次数：383 相关文章

Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies.

PC Wong, EJ Crain, B Xin, RR Wexler… - … of Thrombosis and …, 2008 - europepmc.org
Background Apixaban is an oral, direct and highly selective factor Xa (FXa) inhibitor in late-
stage clinical development for the prevention and treatment of thromboembolic diseases …

[引用][C] Apixaban, an oral, direct and highly selective factor Xa inhibitor:in vitro, antithrombotic and antihemostatic studies

PC WONG, EJ CRAIN, B XIN, RR WEXLER… - Journal of Thrombosis …, 2008 - cir.nii.ac.jp

Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies

PC Wong, EJ Crain, B Xin… - … of thrombosis and …, 2008 - pubmed.ncbi.nlm.nih.gov
Background Apixaban is an oral, direct and highly selective factor Xa (FXa) inhibitor in late-
stage clinical development for the prevention and treatment of thromboembolic diseases …
[HTML] jthjournal.org

[HTML][HTML] Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies

PC WONG, EJ CRAIN, B XIN, RR WEXLER… - Journal of Thrombosis …, 2008 - jthjournal.org
Background: Apixaban is an oral, direct and highly selective factor Xa (FXa) inhibitor in late‐
stage clinical development for the prevention and treatment of thromboembolic diseases …

Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies

PC WONG, EJ CRAIN, B XIN… - … of Thrombosis and …, 2008 - Wiley Online Library
Background: Apixaban is an oral, direct and highly selective factor Xa (FXa) inhibitor in late‐
stage clinical development for the prevention and treatment of thromboembolic diseases …

[引用][C] Apixaban, an oral, direct and highly selective factor Xa inhibitor: In vitro, antithrombotic and antihemostatic studies

W PC - J Thromb Haemost, 2008 - cir.nii.ac.jp
Apixaban, an oral, direct and highly selective factor Xa inhibitor : In vitro, antithrombotic and
antihemostatic studies | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …